CompletedNCT01010750
Official study titleA Phase I, Randomized, Double Blind, Three-Period Crossover, Estimation Study Using Lisdexamfetamine Dimesylate, Immediate Release Mixed Amphetamine Salts and Placebo to Evaluate the Utility of a Standardized Computer Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In HoustonADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Shire
CompletedNCT01328756
What is this study about?Researchers studied Lisdexamfetamine dimesylate, tracking side effects to assess safety and tolerability in children and adolescents with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including HobokenADHDMedication studyAges 6–17
- Countries
- United Kingdom, Belgium, Germany, + 7 others
- Sponsor
- Shire
CompletedNCT00857220
What is this study about?Researchers studied eszopiclone, tracking side effects to assess long-term safety in children with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonADHDMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Sumitomo Pharma America, Inc.
CompletedNCT01081145
What is this study about?This study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including DothanADHDMedication studyAges 6–17
- Countries
- United States, France, Canada, + 7 others
- Sponsor
- Shire
CompletedNCT06012851
Official study titlePersonalizing Behavioral Parent Training: Improving Reach and Outcomes for Families of Children With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In BuffaloADHDBehavioural studyAges 7–12
- Countries
- United States
- Sponsor
- Florida International University